Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data - Fox Business
foxbusiness.comSubmitted by foxbusiness4472 in business
Pfizer expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 after most patients treated for a form of lung cancer had no disease progression after five years.